Please provide your email address to receive an email when new articles are posted on . Treatment led to median decrease from 18 to 6 headache days per month at first follow up after initiation.

Researchers found the drug zonisamide, which has been used to treat seizures, may reduce migraine days in this age group. This study does not prove that zonisamide reduces migraine days ...

We evaluated our clinical experience with zonisamide, a broad-spectrum antiepileptic drug, in a group of children with predominantly medically refractory epilepsy. A retrospective chart review was ...

Significant reduction seen in median headache days per month in both intractable and nonintractable migraine groups. HealthDay News — For pediatric patients with migraine, prophylactic ...